| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |